Contains N-glycolylmuramicacid instead of N-acetylmuramicacid, and has a veryhighlipidcontent, which creates a hydrophobicpermeability barrier
Mycobacteria are difficult to stain
Mycobacteria growth rates
Rapid growers (Visible colonies in <7 days)
Slow growers (Visible colonies in > 7 days)
Major groups of mycobacteria
M. tuberculosis complex
NTM group
Mycobacterial species in M. tuberculosis complex
M.tuberculosis
Mycobacterium bovis
Mycobacterium africanum
Mycobacteriumcaprae
Mycobacterium microti
All species in M.tuberculosis complex are capable of causing tuberculosis
M.tuberculosis is the cause of most cases of human tuberculosis, particularly in developed countries
Inhalation of a single viable M. tuberculosis organism
Leads to infection, although close contact is usually necessary
Ingestion of milk from infected cows
M.bovis may penetrate the gastrointestinalmucosa or invade the lymphatictissue of the oropharynx
An attenuated strain of M.bovis, bacillusCalmette-Guérin (BCG), has been used extensively in many parts of the world to immunize susceptible individuals againsttuberculosis
Tuberculosis may mimic other diseases, such as pneumonia, neoplasm, or fungalinfections
Clinical manifestations of M. tuberculosis complex infection
Asymptomatic
Acutely symptomatic with systemicsymptoms, pulmonary signs and symptoms, signs and symptoms related to other organinvolvement, or a combination of these features
Specimens received by the laboratory for mycobacterial smear and culture must be handled in a safe manner
Acid-fast bacilli can infect almost any tissue or organ of the body
Processing to recover acid-fast bacilli from clinical specimens
1. Decontamination
2. Concentration
Acid-fastness
Characteristic of mycobacteria due to the long-chain, multiplecross-linkedfattyacids (mycolic acids) in their cell walls
Visualization of acid-fast bacilli in sputum or other clinical material should be considered presumptiveevidence of tuberculosis
Ziehl-Neelsen staining
Classic carbolfuchsin stain that requires heating of the slide for better penetration of the stain into the mycobacterialcellwall
With Ziehl-Neelsen staining, Mycobacterium spp. appear red or have a red-blue, beadedappearance, whereas nonmycobacteria appear blue
Drug-resistant tuberculosis is a major health threat
More than 500,000 cases of multidrug-resistant (MDR) tuberculosis occur each year
MDR tuberculosis is resistant to rifampin and isoniazid, the two drugs most often used as effective treatment against tuberculosis
Strains of extensivelydrug-resistanttuberculosis (XDR TB) are emerging that are resistant not only to rifampin and isoniazid, but also to quinolones and other drugs, such as aminoglycosides
Drugs used to treat tuberculosis
Isoniazid
Rifampin
Ethambutol
Pyrazinamide
To prevent the selection of resistant mutants, treatment of tuberculosis requires four drugs